ArticleThe Pan African medical journal2022
Dual mobility total hip replacement: a 15-year experience in Burkina Faso.
Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- Functional and Safety Outcomes of Third-Generation Zimmer Biomet G7Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To report our 15 years of experience in dual mobility total hip replacement (THR) in Burkina Faso through a Franco-Burkinabé relief organization. A retrospective study spanning from 2004 to 2018 was held in a private facility. All dual mobility THR cases with at least one year of follow-up time were included. The survey used a questionnaire, and data were analyzed with statistical software (Stata® v.13). A total of 145 primary THR in 129 patients were included in disabled young patients. There was 60.46% of males (n=78) with a mean age of 44.57 years (SD=12.43). The mean etiologies were avascular necrosis of the hip (n=84), followed by childhood chronic arthritis sequalae (n=24, 16.55%) and trauma sequalae (n=13, 8.97%). All prostheses were metal-on-polyethylene from Zimmer-Biomet®. It was usually small sizes with 48 mm (females) and 50 mm (males) cups, stem 1 (female) and 3 (males). After 2.70 years (SD=2.66) of mean follow-up times, results were good despite a high rate of revision (n=10, 6.89%) due to infections and implant malposition. THR practice might be encouraged in developing countries. The dual mobility concept is adapted to sociological activities. High duration implants and cost limitation is mandatory for the replacement joints diffusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.